Search

Author/Creator Edlund, Helena

1. Exposure–response analysis of acalabrutinib and its active metabolite, ACP‐5862, in patients with B‐cell malignancies. Issue 5 (17th October 2021)

Authors:
Edlund, Helena; Buil‐Bruna, Núria; Vishwanathan, Karthick; Wei, Helen; Raman, Rakesh; de Kock, Miné; He, Zhongqing; Liu, Huan; Baek, Marshall; Ware, Joseph; Patel, Priti; Tomkinson, Helen; Sharma, Shringi
Journal:
British journal of clinical pharmacology
Issue:
Volume 88:Issue 5(2022)
Page Start:
2284
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Improved characterization of the pharmacokinetics of acalabrutinib and its pharmacologically active metabolite, ACP‐5862, in patients with B‐cell malignancies and in healthy subjects using a population pharmacokinetic approach. Issue 2 (21st August 2021)

Authors:
Edlund, Helena; Bellanti, Francesco; Liu, Huan; Vishwanathan, Karthick; Tomkinson, Helen; Ware, Joseph; Sharma, Shringi; Buil‐Bruna, Núria
Journal:
British journal of clinical pharmacology
Issue:
Volume 88:Issue 2(2022)
Page Start:
846
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search